/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Company Overview We are a clinical stage diagnostics company dedicated to improving quality of life and outcomes for the millions of people worldwide who are diagnosed with cancer each year. Our plan is to develop and commercialize a suite of novel genomic tests that support decision making along the entire continuum of oncology care.
$0.12
$0.01 (-7.83%)
Price from 3 days ago
ROIC dropped from -2942.16% to -5817.57%, capital efficiency is deteriorating. Negative free cash flow of -$850K. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$2M
▼ -16.7% YoY
Op. Margin
—
ROIC
-4021.27%
▼ -2875.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$1M
▼ -28.1% YoY
Op. Cash Flow (TTM)
-$1M
▼ -28.1% YoY
Net Debt
$50K
Cash & Equiv.
$13K
Continue Research
SourceComputed from the 10-Q filed 14 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 19 Sept 2026. How this is calculated.
Price from market data, last close as of 17 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.